These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11271079)

  • 41. [Amiodarone (Cordarex) in supraventricular and ventricular arrhythmias refractory to therapy].
    Fortschr Med; 1983 Jan; 101(3):80, 82. PubMed ID: 6826136
    [No Abstract]   [Full Text] [Related]  

  • 42. Acute amiodarone toxicity due to an administration error: could excipient be responsible?
    Masi S; de Cléty SC; Anslot C; Detaille T
    Br J Clin Pharmacol; 2009 Jun; 67(6):691-3. PubMed ID: 19076154
    [No Abstract]   [Full Text] [Related]  

  • 43. [Does amiodarone have a benefit effect on mortality?].
    Pathé M; Kahn JC
    Presse Med; 1991 Sep; 20(28):1330-4. PubMed ID: 1833737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Amiodarone].
    Hein L
    Dtsch Med Wochenschr; 2001 May; 126(21):625-6. PubMed ID: 11413750
    [No Abstract]   [Full Text] [Related]  

  • 45. Amiodarone.
    Smith WC; Reddy CP
    J La State Med Soc; 1989 May; 141(5):35-8. PubMed ID: 2659709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacologic management of arrhythmias.
    Bink-Boelkens MT
    Pediatr Cardiol; 2000; 21(6):508-15. PubMed ID: 11050274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amiodarone for cardiac arrhythmias. Key management issues for NPs.
    McLemore R
    Adv Nurse Pract; 2001 Apr; 9(4):69-71. PubMed ID: 12420439
    [No Abstract]   [Full Text] [Related]  

  • 48. [Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
    Fujiki A
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):253-60. PubMed ID: 16536075
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
    Marcus FI; Fontaine GH; Frank R; Grosgogeat Y
    Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975
    [No Abstract]   [Full Text] [Related]  

  • 50. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants.
    Etheridge SP; Craig JE; Compton SJ
    Am Heart J; 2001 Jan; 141(1):105-10. PubMed ID: 11136494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy and safety of intravenous Amiodarone in infants and children.
    Figa FH; Gow RM; Hamilton RM; Freedom RM
    Am J Cardiol; 1994 Sep; 74(6):573-7. PubMed ID: 8074040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?
    Yildirim SV; Tiker F; Cengiz N; Kiliçdağ H
    Pediatr Cardiol; 2005; 26(6):879-80. PubMed ID: 16235017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxic effects of drugs used in the ICU. Antiarrhythmic agents.
    Nolan PE; Raehl CL
    Crit Care Clin; 1991 Jul; 7(3):507-20. PubMed ID: 1863880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous amiodarone.
    Dimens Crit Care Nurs; 2000; 19(1):29. PubMed ID: 10876483
    [No Abstract]   [Full Text] [Related]  

  • 55. Dronedarone: NICE enough?
    Khoo CW; Lim HS; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1049-51. PubMed ID: 20670181
    [No Abstract]   [Full Text] [Related]  

  • 56. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW; Finerman WB; Peter T; Mandel WJ
    Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Fetal supraventricular tachyarrhythmias refractory to initial therapy].
    Malvino E; Bruno MC; Gallo JP; Medrano JC; Ferrante D
    Medicina (B Aires); 2005; 65(2):138-42. PubMed ID: 16075808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol.
    Perry JC; Fenrich AL; Hulse JE; Triedman JK; Friedman RA; Lamberti JJ
    J Am Coll Cardiol; 1996 Apr; 27(5):1246-50. PubMed ID: 8609351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent].
    Malpartida F; Triola M; Huguet R; Sala J; Noguera J; Cordeiro B
    Rev Med Univ Navarra; 1975; 19(1):143-9. PubMed ID: 1234780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
    Schmidt A; König W; Binner L; Mayer U; Stauch M
    Clin Cardiol; 1988 Jul; 11(7):481-5. PubMed ID: 3416512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.